Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide

Area of Science:

• Pharmacology
• Biochemistry
• Materials Science

Background:

• Anandamide (arachidonylethanolamide; AEA) is an endogenous cannabinoid receptor ligand with significant pharmacological interest.
• Low aqueous solubility and stability of AEA limit its therapeutic applications and experimental reliability.

Purpose of the Study:

• To investigate the potential of cyclodextrin (CD) complexation to enhance the aqueous solubility and stability of anandamide (AEA).

Main Methods:

• Formation of inclusion complexes between AEA and various cyclodextrins (CDs).
• Quantification of aqueous solubility enhancement.
• Assessment of AEA stability in aqueous CD solutions at elevated temperatures.

Main Results:

• AEA/CD complexes exhibited significantly increased aqueous solubility, ranging from 1,000 to 30,000-fold depending on the CD type.
• The half-life of AEA in a 10% hydroxypropyl-beta-cyclodextrin solution at 50°C was determined to be 2.9 years.
• CD complexation effectively mitigated AEA degradation in aqueous environments.

Conclusions:

• Cyclodextrin technology offers a viable strategy to overcome the inherent solubility and stability limitations of anandamide (AEA).
• Enhanced AEA solubility and stability through CD complexation can improve the reliability of pharmacological studies and therapeutic development.